Cargando…

Cost-Effectiveness of Intranasal Live-Attenuated Influenza Vaccine for Children: A Systematic Review

Introduction: The public health burden of seasonal influenza is significant, and influenza vaccination is the most effective preventive strategy. Nonetheless, the recommendation of influenza immunization in the pediatric population is still underrepresented. Our work aimed to assess the cost-effecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Kenneth Sik-Kwan, Wong, Charlene Hoi-Lam, Choi, Horace Cheuk-Wai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505322/ https://www.ncbi.nlm.nih.gov/pubmed/36146544 http://dx.doi.org/10.3390/vaccines10091466

Ejemplares similares

Overall Survival Benefits of First-Line Treatments for Asian Patients with Advanced Epidermal Growth Factor Receptor-Mutated NSCLC Harboring Exon 19 Deletion: A Systematic Review and Network Meta-Analysis
por: Chan, Sik-Kwan, et al.
Publicado: (2022)

Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany
por: Damm, Oliver, et al.
Publicado: (2014)

Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia
por: Armitage, Edwin P., et al.
Publicado: (2018)

Respiratory PCR detects influenza after intranasal live-attenuated influenza vaccination
por: Lumley, S, et al.
Publicado: (2013)

Treatment-Related Adverse Events of Combination EGFR Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor in EGFR-Mutant Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Chan, Daisy Wai-Ka, et al.
Publicado: (2022)

Cost-effectiveness of Pembrolizumab as a Second-Line Therapy for Hepatocellular Carcinoma
por: Chiang, Chi-leung, et al.
Publicado: (2021)

First-Line Atezolizumab Plus Bevacizumab versus Sorafenib in Hepatocellular Carcinoma: A Cost-Effectiveness Analysis
por: Chiang, Chi-Leung, et al.
Publicado: (2021)

Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents
por: Tarride, Jean-Eric, et al.
Publicado: (2012)

Use of intranasal live attenuated influenza vaccine in individuals with asthma or a history of wheezing
por: Ambrose, Christopher S.
Publicado: (2012)

Cost-effectiveness analysis of the direct and indirect impact of intranasal live attenuated influenza vaccination strategies in children: alternative country profiles
por: Gibson, Edward, et al.
Publicado: (2016)

Safety and Efficacy of Spray Intranasal Live Attenuated Influenza Vaccine: Systematic Review and Meta-Analysis
por: Perego, Giulia, et al.
Publicado: (2021)

Influenza Virus Detection Following Administration of Live-Attenuated Intranasal Influenza Vaccine in Children With Cystic Fibrosis and Their Healthy Siblings
por: Boikos, Constantina, et al.
Publicado: (2016)

Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets
por: Luczo, Jasmina M., et al.
Publicado: (2021)

Vaccination of children with a live-attenuated, intranasal influenza vaccine – analysis and evaluation through a Health Technology Assessment
por: Andersohn, Frank, et al.
Publicado: (2014)

Overall Survival Benefits of First-Line Treatments for Asian Patients With Advanced EGFR-Mutated NSCLC Harboring L858R Mutation: A Systematic Review and Network Meta-Analysis
por: Chan, Sik-Kwan, et al.
Publicado: (2022)

2610. Home Administration of Intranasal Live Attenuated Influenza Vaccine: A Review of Current Evidence and Potential for Meeting Vaccination Targets
por: Jhaveri, Ravi, et al.
Publicado: (2023)

The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles
por: Tarabichi, Y., et al.
Publicado: (2015)

Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England
por: McNaughton, Rhian, et al.
Publicado: (2016)

Intranasal sedatives in pediatric dentistry
por: AlSarheed, Maha A.
Publicado: (2016)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
por: Sridhar, Saranya, et al.
Publicado: (2015)

Acceptance of COVID-19 Vaccination in Cancer Patients in Hong Kong: Approaches to Improve the Vaccination Rate
por: Chan, Wing-Lok, et al.
Publicado: (2021)

Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
por: Park, Jun-Gyu, et al.
Publicado: (2021)

Prognostic Biomarkers for Survival in Nasopharyngeal Carcinoma: A Systematic Review of the Literature
por: Islam, Kazi Anisha, et al.
Publicado: (2022)

Immune responses after live attenuated influenza vaccination
por: Mohn, Kristin G.-I., et al.
Publicado: (2018)

Novel Approaches for The Development of Live Attenuated Influenza Vaccines
por: Blanco-Lobo, Pilar, et al.
Publicado: (2019)

Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
por: You, Joyce HS, et al.
Publicado: (2014)

Reflex Effects of Intranasal Disease in the Pharynx and Mouth
por: Clark, Horace
Publicado: (1897)

Seasonal influenza in children: Costs for the health system and society in Europe
por: Villani, Leonardo, et al.
Publicado: (2022)

Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines
por: Wang, Pui, et al.
Publicado: (2019)

584. Phase 1 Placebo-Controlled Trial of COVI-VAC™, an Intranasal, Live Attenuated COVID-19 Vaccine
por: Tasker, Sybil, et al.
Publicado: (2021)

Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine
por: Wright, Peter F., et al.
Publicado: (2016)

Broadly Neutralizing Antibodies for Influenza: Passive Immunotherapy and Intranasal Vaccination
por: Biswas, Mrityunjoy, et al.
Publicado: (2020)

Single HA2 Mutation Increases the Infectivity and Immunogenicity of a Live Attenuated H5N1 Intranasal Influenza Vaccine Candidate Lacking NS1
por: Krenn, Brigitte M., et al.
Publicado: (2011)

Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives
por: Xu, Yingying, et al.
Publicado: (2014)

Live Attenuated Influenza Vaccines by Computer-Aided Rational Design
por: Mueller, Steffen, et al.
Publicado: (2010)

Principles underlying rational design of live attenuated influenza vaccines
por: Jang, Yo Han, et al.
Publicado: (2012)

Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine
por: Martínez-Sobrido, Luis, et al.
Publicado: (2018)

Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges
por: Lee, Andrew Chak-Yiu, et al.
Publicado: (2021)

Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza
por: Ambrose, Christopher S., et al.
Publicado: (2008)

Severity of heterosubtypic influenza virus infection in ferrets is reduced by live attenuated influenza vaccine
por: Marriott, Anthony C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8r43jpdag2n51pie9sdjuodk15